Date: 2013-07-02
Type of information: Company acquisition
Acquired company: Constitution Medical Investors (USA)
Acquiring company: Roche (Switzerland)
Amount: $ 220 million and further contingent payments depending on the achievement of certain milestones
Terms: * On July 2, 2013, Roche has announced that it has acquired Constitution Medical Investors, Inc. (CMI), based in Boston Massachusetts (USA). CMI is the developer of a highly innovative hematology testing system, which is designed to provide faster and more accurate diagnosis of blood-related diseases, thereby improving patient care. CMI was created and funded by the private equity firm Warburg Pincus and members of CMI’s management team. Under the terms of the agreement, Roche will pay CMI shareholders $ 220 million upfront, as well as further contingent payments depending on the achievement of certain milestones. CMI will serve as a center of excellence in the field of hematology within Roche Diagnostics.CMI has developed the Bloodhound™ technology, a fully-automated system in development with the capability to increase efficiency and save laboratory space by replacing several workstations with a single, compact unit. The new hematology capabilities will support Roche’s growth and strengthen its competitive position in the laboratory hematology testing business, which has an estimated global market size of more than $ 2.0 billion.
Details:
Related: diagnostic
hematology
